Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies

Conclusions The findings suggest that higher levels of pretransplant circulating antibodies against AT1R (>30 U) in kidney graft recipients constitute an independent risk factor for earlier de novo HLA-DSA detection during the posttransplant period.

http://ndt.oxfordjournals.org/cgi/content/short/31/10/1738?rss=1

Source: Nephrology Dialysis Transplantation - September 27, 2016 Category: Urology & Nephrology Authors: Cuevas, E., Arreola-Guerra, J. M., Hernandez-Mendez, E. A., Salcedo, I., Castelan, N., Uribe-Uribe, N. O., Vilatoba, M., Contreras-Saldivar, A. G., Sanchez-Cedillo, A. I., Ramirez, J. B., de Rungs, D., Granados, J., Morales-Buenrostro, L. E., Alberu, J. Tags: Renal Transplantation Source Type: research